In one paragraphArticle in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
24 authors.
Garrett J StevensDepartment of Bioengineering, Stanley Hall, University of California, Berkeley CA 94720, USA.ORCID 0000-0002-9781-5323 Kyösti SutinenEuropean Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, United Kingdom.
Dario BeraldiGlasgow Centre for Parasitology, School of Infection and Immunity, University of Glasgow, Glasgow G12 8TA, United Kingdom.ORCID 0000-0003-1504-5212 Shashank Budhanuru RamarajuEuropean Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, United Kingdom.ORCID 0000-0001-8907-5313 Colin DieshDepartment of Bioengineering, Stanley Hall, University of California, Berkeley CA 94720, USA.ORCID 0000-0003-2629-7570 William Haese-HillGlasgow Centre for Parasitology, School of Infection and Immunity, University of Glasgow, Glasgow G12 8TA, United Kingdom.ORCID 0000-0002-1393-0966 Peter XieDepartment of Bioengineering, Stanley Hall, University of California, Berkeley CA 94720, USA.
Caroline BridgeAdaptive Oncology, Ontario Institute for Cancer Research, MaRS Centre, 661 University Avenue, Suite 510, Toronto, Ontario M5G 0A3, Canada.ORCID 0000-0002-7913-8832 Adrien MorisonGlasgow Centre for Parasitology, School of Infection and Immunity, University of Glasgow, Glasgow G12 8TA, United Kingdom.ORCID 0000-0002-8261-9143 Angel LeungDepartment of Bioengineering, Stanley Hall, University of California, Berkeley CA 94720, USA.ORCID 0009-0002-3725-957X Ulrike BöhmeInstitute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool L69 7BE, United Kingdom.ORCID 0000-0002-0248-5924 Scott CainDepartment of Biochemistry and Molecular Biology, 505 Wartik Laboratory, Pennsylvania State University, State College PA 16801, USA.ORCID 0000-0003-0459-9607 Nathan DunnDepartment of Bioengineering, Stanley Hall, University of California, Berkeley CA 94720, USA.ORCID 0000-0002-4862-3181 Toby HuntEuropean Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, United Kingdom.ORCID 0000-0001-8377-0841 Jane E LovelandEuropean Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, United Kingdom.ORCID 0000-0002-7669-2934 Adam FrankishEuropean Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, United Kingdom.ORCID 0000-0002-4333-628X Alexie PapanicolauDepartment of Biochemistry and Molecular Biology, 505 Wartik Laboratory, Pennsylvania State University, State College PA 16801, USA.ORCID 0000-0002-3635-6848 Stefano GiorgettiEuropean Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, United Kingdom.ORCID 0000-0001-5424-9723 Jon KeatleyEuropean Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, United Kingdom.ORCID 0000-0001-9485-1743 Bethany FlintEuropean Molecular Biology Laboratory, European Bioinformatics Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, United Kingdom.ORCID 0000-0001-5881-6430 Lincoln SteinAdaptive Oncology, Ontario Institute for Cancer Research, MaRS Centre, 661 University Avenue, Suite 510, Toronto, Ontario M5G 0A3, Canada.ORCID 0000-0002-1983-4588 Robert BuelsDepartment of Bioengineering, Stanley Hall, University of California, Berkeley CA 94720, USA.ORCID 0000-0002-9605-5895 Matt BerrimanGlasgow Centre for Parasitology, School of Infection and Immunity, University of Glasgow, Glasgow G12 8TA, United Kingdom.ORCID 0000-0002-9581-0377 Ian HolmesDepartment of Bioengineering, Stanley Hall, University of California, Berkeley CA 94720, USA.ORCID 0000-0001-7639-5369 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
We present Apollo 3, a new manual genome annotation tool that integrates with the JBrowse 2 genome browser. Its functionality is inspired by existing manual genome annotation tools such as Apollo, Artemis, and Otter, combining features from those tools with an updated and more scalable architecture and technology stack. It allows simultaneous editing of multiple genomes, including visualization of synteny to inform those annotations. Apollo 3 can be used as a standalone annotation editor, or it can be installed on a server and used collaboratively.
Identifiers
PMID42327079
PMCPMC13277961
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390